ID   HLR
AC   CVCL_KB15
SY   Hlr; PathDetect HLR; HeLa Luciferase Reporter
DR   Wikidata; Q54889860
RX   PubMed=11355349;
WW   Provider; Agilent; 800050; https://www.chem-agilent.com/pdf/strata/800050.pdf
CC   Population: African American.
CC   Characteristics: The luciferase reporter gene expression is under the control of a synthetic promoter containing 5 direct repeats of the 17-mer GAL4-binding site.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Firefly luciferase.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Agilent/Stratagene; Catalog number 800050.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
RX   PubMed=11355349; DOI=10.2144/01305dd06;
RA   Hexdall L., Zheng C.-F.;
RT   "Stable luciferase reporter cell lines for signal transduction pathway
RT   readout using GAL4 fusion transactivators.";
RL   BioTechniques 30:1134-1140(2001).
//